Join our 2-part webinar series! Intro to qPCR and role of RNAs as biomarkers in cardiovascular research

S_2945_GG_Cardio_RP_700x233

Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide. Preventative and therapeutic strategies focused on controlling traditional risk factors have not always been successful. Recently, the use of miRNAs as novel biomarkers in CVD has opened up new possibilities for discovering novel therapeutic targets and understanding CVD development. To date, the total number of miRNAs encoded in the human genome surpasses 1,000.

In this 2-part webinar series, the first part will focus on qPCR technology and associated challenges and solutions. The second part will cover why and how microRNAs are being investigated as biomarkers for CVD, as well as examine some recent findings in the field. Join us to find out how scientists are investigating the role of noncoding RNA in CVD and how you can get started in your lab!

Save your spot for the live presentation and take this opportunity to get your questions answered by the experts.

2-part webinar series: Introduction to qPCR and RNAs as biomarkers in cardiovascular diseases – a case study

Part 1: Introduction to real-time PCR (q-PCR/qPCR/qRT-PCR)

April 11, 9:30 a.m. EDT, 2:30 pm. GMT, 3:30 p.m. CEST

Speaker: Dr. Vishwadeepak Tripathi, Global Marketing Manager – QIAGEN

Join now:  https://attendee.gotowebinar.com/register/4412009590655294466

Part 2: Noncoding RNAs in cardiovascular disease – potential as biomarkers and more

April 18, 9:30 am EDT, 2:30 pm GMT, 3:30 pm CEST

Speaker: Dr. Allison Bierly, Global Market Manager – QIAGEN

Join now: https://attendee.gotowebinar.com/register/4412009590655294466
Scheduling conflict? Don’t worry! Register now and you’ll receive a link to view an on-demand recording after the event.

We look forward to addressing the challenges you face in qPCR technology and miRNA expression profiling as biomarkers in your cardiovascular disease research.

Sign up for the live webinar! 

Vishwadeepak Tripathi

Vishwadeepak Tripathi, PhD is a Global Market Manager at QIAGEN. He received his PhD in biochemistry at the Faculty of Medicine from Ruhr-University Bochum, Germany. Dr. Tripathi studied the role of chaperones and co-chaperones in protein folding and quality control and authored a number of scientific publications. He was also at RIKEN Institute in Japan where he studied the pathogenesis of Huntington's disease in cellular and mice models. He is currently interested in biomarker research, NGS and neurodegeneration.

Your email address will not be published. Required fields are marked *